Back to Journal

SM Journal of Nephrology and Kidney Diseases

Systematic Review of Influencing Factors for Oral Frailty in Maintenance Hemodialysis Patients

[ ISSN : 2576-5450 ]

Abstract Citation BACKGROUND METHODS RESULTS DISCUSSION CONCLUSIONS DECLARATIONS CONSENT FOR PUBLICATION AVAILABILITY OF DATA AND MATERIALS FUNDING AUTHORS’ CONTRIBUTIONS REFERENCES
Details

Received: 15-Jun-2026

Accepted: 30-Jun-2026

Published: 02-Jul-2026

Wenhui Chang1, Jia Xu2*, Ying Yu2, Yayu Zhao3, Xinru Wei3, and Xiaoqi Li3

1Shanxi University of Chinese Medicine, Jinzhong, China

2Shanxi Bethune Hospital, China

3Shanxi University of Chinese Medicine, Jinzhong, China

Corresponding Author:

Jia Xu, Shanxi Bethune Hospital, Taiyuan, China, Tel: 13934517297

Keywords

Hemodialysis; Oral Frailty; Oral Health; Systematic Review

Abstract

Background: There are over one million dialysis patients in China, 80% of whom receive maintenance hemodialysis. Long-term dialysis increases the risk of oral frailty. This study reviews its influencing factors to provide evidence for early prevention and control.

Objective: This study conducted a systematic review of the factors associated with the occurrence of oral frailty in maintenance hemodialysis (MHD) patients based on relevant literature, to provide a reference for the clinical prevention of oral frailty in this population.

Methods: Computerized searches were performed in CNKI, WanFang Data, VIP Database, CBM, PubMed, Web of Science, Embase, and Cochrane Library from the establishment of each database to February 9, 2026. Quality assessment and analysis were conducted on the included literature.

Results: A total of 7 studies involving 1450 participants were finally included. The results of the meta-analysis showed that advanced age, sarcopenia, and malnutrition were risk factors for oral frailty in MHD patients, while higher grip strength and higher educational level were protective factors.

Conclusion: The factors influencing the occurrence of oral frailty in MHD patients are diverse and complex. In clinical practice, nursing staff should pay attention to the oral health of patients, identify the influencing factors, and implement interventions as early as possible. In the future, a risk prediction model for oral frailty in MHD patients should be constructed and validated to provide further evidence in support of relevant clinical interventions.

Citation

Chang W, Xu J, Yu Y, Zhao Y, Wei X, et al. (2026) Systematic Review of Influencing Factors for Oral Frailty in Maintenance Hemodialysis Patients. J Nephrol Kidney Dis 7(1): 1043..

BACKGROUND

Data from the China Kidney Disease Network showed that by the end of 2023, there were 1.069 million dialysis-dependent patients in China, among whom approximately 80% relied on maintenance hemodialysis (MHD) [1]. Oral frailty (OF) is an emerging concept in geriatric syndromes, with no unified definition yet. The Joint Committee for Oral Frailty in Japan recommended an operational definition including a reduced number of teeth, difficulty chewing, dysphagia, xerostomia, and decreased oral motor skills [2].

Long-term dialysis leads to reduced saliva secretion, impaired immune function, and combined effects of various medications, resulting in poorer oral health status in most MHD patients, such as xerostomia, dental caries, and periodontitis, which increase the risk of OF [3-5]. Studies have demonstrated that OF is a critical determinant of malnutrition and sarcopenia progression in hemodialysis patients [6]. Identifying influencing factors of OF and implementing early interventions may reduce adverse outcomes in MHD patients. Therefore, this study systematically reviewed the influencing factors of OF in MHD patients to provide evidence for early clinical prevention.

METHODS

Ethical Considerations

This systematic review is based solely on previously published studies and does not involve the collection of primary data from human participants or animals. Therefore, ethical approval was not required for this study. All included studies were conducted in accordance with relevant ethical guidelines, and A study protocol for this systematic review was registered in the PROSPERO database (CRD420261281051) but was not published in a peer-reviewed journal.

Search Strategy

Computerized searches were conducted in CNKI, WanFang Data, VIP Database, CBM, PubMed, Web of Science, Embase, and Cochrane Library from database inception to February 9, 2026. Chinese search terms included “肾透析”, “血液透析”, “维持性血液透析”, “ 口腔衰弱”, “口腔功能障碍”, “口腔功能减退”. English search terms included “renal dialysis”, “dialysis”, “hemodialysis”, “maintenance hemodialysis”, “oral frailty”, “oral weakness”, “oral asthenia”, “oral fragility”, “oral function”, and “oral health”. Taking CNKI as an example, the Chinese search formula was: (SU= ‘肾透析’ + ‘维持性血液透析’ + ‘ 血液透析’ ) AND ( SU= ‘口腔衰弱’ + ‘口腔功能障碍’ + ‘口腔功 能下降’ ). The detailed search strategy for PubMed is shown in Figure 1.

Figure 1: PubMed search strategy

Inclusion and Exclusion Criteria

Inclusion criteria:(1)Study population:MHD patients;(2)Outcome measures:identification of potential influencing factors for oral frailty;(3) Study design:cohort studies, cross-sectional studies, and case-control studies;(4)Assessment tools:validated oral frailty measurement scales. And the exclusion criteria:(1)Duplicated publications;(2)Low-quality studies;(3)Non-Chinese and non-English literature;(4)Unavailable full text articles.

Literature Screening and Data Extraction

Retrieved literatures were imported into Note Express 4.0.0 for deduplication. Two postgraduate nursing students(C and Z) independently screened the literature according to inclusion and exclusion criteria. Initially, irrelevant literatures were excluded by reading titles and abstracts. Potentially eligible studies were further assessed by full-text reading. Discrepancies were resolved via discussion or consultation with experienced teachers in evidence-based practice. Extracted data included author, country/region, publication year, study design, sample size, assessment tool, prevalence, influencing factors, etc.

Quality Assessment of Included Studies

Cross-sectional studies were evaluated using the Agency for Healthcare Research and Quality (AHRQ) scale (11 items, 1 point for “yes”, 0 points for “no”, “unclear” or “not applicable”; classified as low quality: 0–3, moderate quality: >3–7, high quality: >7–11) [7]. Cohort studies were assessed using the Newcastle-Ottawa Scale (NOS) (9 items, 1 point for “yes”, 0 points for “no” or “unclear”; classified as high quality: ≥7, moderate quality: 5–6, low quality: 0–4) [8].

Statistical Analysis

RevMan5.4.1 was used for data analysis. Effect sizes were presented as pooled odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity was evaluated using the I² statistic. A fixed-effects model was applied if I² ≤ 50% and P ≥ 0.1; otherwise, a random-effects model was used. Descriptive analysis was performed for influencing factors unsuitable for meta-analysis. P < 0.05 was considered statistically significant.

RESULTS

Literature Screening Results

A total of 1,538 records were initially retrieved. After screening, 7 studies were finally included.

The detailed process is shown in Figure 2.

Figure 2: Literature Screening Flowchart

Basic Characteristics of Included Studies

7 studies [6-14], published between 2023 and 2025 were included, with a total sample size of 1,450. The prevalence of oral frailty in MHD patients ranged from 38.8% to 61.2%. The basic characteristics are summarized in Table 1.

Table 1: Basic characteristics of included studies (n=7)

Author

Year

Country

Study type

Sample

size

Assessment tool

Prevalence

Influencing factors

Quality

assessment

Masanori[9]

2023

Japan

Cross-sectional study

152

Oral Frailty Index-5

61.2%

Age, malnutrition

8

 

Dou[10]

 

2024

 

China

 

Cross-sectional study

 

238

 

Oral Frailty Index-8

 

41.2%

Educational level, grip strength, age-adjusted Charlson Comorbidity Index (aCCI),

appetite

 

6

 

Miyasato[6]

 

2024

 

Japan

 

Cohort study

 

201

 

Oral Frailty Index-8

 

38.8%

 

Age, frailty

 

8

 

Chen[11]

 

2024

 

China

 

Cross-sectional study

 

325

 

Oral Frailty Index-8

 

45.2%

Oral health knowledge, oral health behavior score, dialysis adequacy, number of teeth, OHAT

score, swallowing abnormality

 

7

 

Mei[12]

 

2025

 

China

Cross-sectional study

 

237

 

Oral Frailty Index-8

 

40.9%

Sarcopenia, grip strength, walking speed

 

5

Wang[13]

2025

China

Cross-sectional study

182

Oral Frailty Index-8

51.7%

Age, educational level, xerostomia severity

5

 

li[14]

 

2025

 

China

 

Cross-sectional study

 

115

 

Oral Frailty Index-8

 

40.87%

Sarcopenia, malnutrition, smoking, hypertension, monthly household income, depression, cognitive impairment

 

5

Meta-Analysis Results

1. Demographic Factors: Pooled analyses were performed for factors reported in ≥2 studies. Three studies [6-13], identified age as an influencing factor for oral frailty in MHD patients. Among them, Wang’s study [13], used 60 years as the cutoff point and found that MHD patients aged ≥60 years had a significantly higher risk of oral frailty than those aged <60 years (OR=10.145, 95% CI: 1.754–58.659). The other two studies [9-13], did not use 60 years as the cutoff point; therefore, these 2 studies were included in the meta-analysis. The heterogeneity test showed I²=0% and P=0.76, so a fixed-effects model was applied. The results indicated that older patients had a significantly higher risk of oral frailty than younger patients (OR=1.06, 95% CI: 1.04–1.09, P<0.05), suggesting that advanced age may be a risk factor for oral frailty in MHD patients (Figure 3).

Figure 3: Meta-analysis of the effect of age on oral frailty in MHD patients

Two studies [10-13], reported educational level as an influencing factor for oral frailty in MHD patients. The heterogeneity test showed I²=30%, P=0.23, so a fixed-effects model was used for analysis. The meta analysis results demonstrated that patients with a higher educational level had a lower risk of oral frailty than those with a lower educational level (OR=0.55, 95% CI: 0.38–0.80, P<0.05), suggesting that a higher educational level may be a protective factor against oral frailty in MHD patients (Figure 4).

Figure 4: Meta-analysis of the effect of educational level on oral frailty in MHD patients

In addition, several studies [14], have reported that other demographic factors, including smoking history, hypertension history, and monthly household income, are also influencing factors for oral frailty in MHD patients.

2. Oral-Related Factors: Only one study was available for each oral related factor; thus, descriptive analysis was conducted. Two studies [11-13], reported that oral-related factors, including oral health literacy, xerostomia severity, number of teeth, and abnormal swallowing, were associated with the occurrence of oral frailty in MHD patients. Among them, Wang’s study [13], found a strong correlation between oral frailty and xerostomia in MHD patients. Specifically, each 1-point increase in the SXI total score was associated with a 32.977-fold higher risk of oral frailty

XI total score was associated with a 32.977-fold higher risk of oral frailty. 1.1.1 Disease and Treatment-Related Factors: Pooled analyses were conducted for factors reported in at least 2 studies. Two studies [10,12], identified grip strength as an influencing factor for oral frailty in MHD patients. The heterogeneity test showed I²=0% and P=0.62, so a fixed-effects model was applied. The meta-analysis results indicated that patients with higher grip strength had a lower risk of oral frailty than those with lower grip strength (OR=0.92, 95% CI: 0.88–0.95, P<0.05), suggesting that higher grip strength may be a protective factor against oral frailty in MHD patients (Figure 5).

Figure 5: Meta-analysis of the effect of grip strength on oral frailty in MHD patients

Two studies [9-14], reported malnutrition as an influencing factor for oral frailty in MHD patients. The heterogeneity test showed I²=57% and P=0.13, so a random-effects model was used for analysis. The meta-analysis results demonstrated that patients with malnutrition had a higher risk of oral frailty than those with good nutritional status (OR=3.63, 95% CI: 1.29–10.22, P<0.05), suggesting that malnutrition may be a risk factor for oral frailty in MHD patients (Figure 6).

Figure 6: Meta-analysis of the effect of malnutrition on oral frailty in MHD patients

Two studies [12-14], identified sarcopenia as an influencing factor for oral frailty in MHD patients. The heterogeneity test showed I²=0% and P=0.86, so a fixed-effects model was used for analysis. The meta-analysis results indicated that patients with sarcopenia had a significantly higher risk of oral frailty than those without sarcopenia (OR=3.64, 95% CI: 1.77 7.47, P<0.05), suggesting that sarcopenia may be a risk factor for oral frailty in MHD patients (Figure 7).

Figure 7: Meta-analysis of the effect of sarcopenia on oral frailty in MHD patients

In addition, several studies [6-11], also reported that other disease and treatment-related factors, including dialysis adequacy, Charlson Comorbidity Index, and physical frailty, were also associated with oral frailty in MHD patients.

7. Psychological and Cognitive Factors: Only one study was included for each psychological and cognitive factor; thus, descriptive analysis was performed. A study by Li [14], showed that cognitive impairment and depression were significantly associated with the occurrence of oral frailty in MHD patients (P < 0.05) and increased the risk of oral frailty in this population.

DISCUSSION

Advanced Age as a Risk Factor

The present study demonstrated that advanced age was a risk factor for oral frailty in MHD patients. With aging, the activity of alkaline phosphatase in periodontal ligament cells, as well as their regenerative and osteogenic capacity, decreases. In addition, elderly individuals experience physiological changes such as gingival atrophy, tooth demineralization, and cementum softening, which may increase the incidence of periodontitis and dental caries [15], thereby raising the risk of oral frailty. Meanwhile, MHD patients present with disorders of mineral and bone metabolism, alkalization of the oral environment, and suppressed immune function due to underlying disease and dialysis related factors. These changes also increase the prevalence of oral health problems, including ammonia odor, xerostomia, and periodontitis [16,17], further elevating the risk of oral frailty. The combined effects of these two pathways significantly increase the risk of oral frailty in elderly MHD patients. Therefore, clinical practice should focus on oral problems in elderly MHD patients, conduct regular screening for oral frailty in this population, and provide early intervention for high-risk individuals to prevent the progression of oral frailty.

A higher educational level is a protective factor against oral frailty in MHD patients

The present study showed that a higher educational level is a protective factor against oral frailty in MHD patients. Individuals with lower educational attainment often have limited oral health knowledge and literacy, insufficient awareness of the importance of oral health, and thus develop unhealthy oral hygiene habits, leading to a series of oral problems [18], and increasing the risk of oral frailty. However, studies have shown that only 29.6% of the population has some understanding of oral frailty, indicating that public awareness of oral frailty and the importance of oral health needs to be improved [19]. Therefore, strengthening oral health education for this population is particularly important. Saengtipbovorn implemented interventions including oral health consultation, individualized oral hygiene instruction, and intensive video-based education, which improved glycemic control and periodontal status in elderly patients with diabetes, demonstrating that oral health education can effectively modify oral health behaviors and reduce the occurrence of oral health problems [20]. This suggests that in clinical practice, we can prevent the occurrence of oral frailty by enhancing MHD patients’ awareness of the importance of oral health and modifying their unhealthy oral hygiene habits and behaviors. We can strengthen patients’ attention to oral health through measures such as producing and distributing oral health pamphlets, conducting free oral health screenings, and establishing WeChat groups to share videos and knowledge related to oral health.

Sarcopenia and Malnutrition are Risk Factors for the Development of Oral Frailty in MHD Patients

The present study demonstrated that sarcopenia and malnutrition are risk factors for the development of oral frailty in MHD patients. Grip strength is one of the important clinical indicators for the diagnosis of sarcopenia [21], and this study found that higher grip strength is a protective factor against oral frailty in MHD patients. Sarcopenia, also known as muscle atrophy or muscle wasting, is an age-related degenerative disorder characterized by reduced muscle mass, decreased muscle strength, and impaired physical function [22]. Studies have shown that sarcopenia leads to declines in multiple oral functions, including bite force, masticatory function, and swallowing function [23], thereby increasing the risk of oral frailty. Patients with poor oral function tend to avoid hard foods such as meat, fruits, and vegetables, which are major sources of dietary protein; long-term low-protein intake is unfavorable for muscle repair and growth [24], further exacerbating sarcopenia and forming a vicious cycle of “sarcopenia–oral frailty–malnutrition worsening sarcopenia”, with the three conditions interacting closely and inextricably linked. A study by Guo Zixin reported a 39.9% comorbidity rate of oral frailty and sarcopenia [23], and a cohort study indicated that oral frailty is a significant determinant of malnutrition and sarcopenia progression in MHD patients aged 65 years and older [6]. This suggests that clinicians should not overlook the importance of oral frailty, strengthen oral health education for patients, recognize the interactions between sarcopenia, oral frailty, and malnutrition, implement early combined screening and comprehensive interventions to break the vicious cycle, and further conduct large-sample, high-quality longitudinal studies to explore the underlying mechanisms, providing evidence-based support for targeted prevention and treatment strategies to improve the overall health of MHD patients.

CONCLUSIONS

This study systematically evaluated the influencing factors of oral frailty in MHD patients and comprehensively summarized the effects of demographic factors, oral-related factors, disease and treatment-related factors, as well as psychological and cognitive factors on oral frailty. Advanced age, sarcopenia, and malnutrition were identified as risk factors for oral frailty in MHD patients, while higher educational level and greater grip strength were protective factors. These findings may provide a reference for the clinical early prevention of oral frailty in MHD patients.However, this study has certain limitations: the number of included literature for some influencing factors was relatively small, which may have a certain impact on the results. It is suggested that large-sample and high-quality studies be conducted in the future to further explore the pathogenesis and influencing factors of oral frailty in MHD patients, and to establish and validate a risk prediction model for oral frailty in this population, so as to provide further evidence for clinical interventions.

DECLARATIONS

Ethics Approval and Consent to Participate

This systematic review is based solely on previously published studies and does not involve the collection of primary data from human participants or animals. Therefore, ethical approval was not required for this study.

CONSENT FOR PUBLICATION

Some of the images and tables were included in our study, and we have published them with the consent of all authors.

AVAILABILITY OF DATA AND MATERIALS

The datasets related to this study are available upon contact with the corresponding author.

FUNDING

This study was supported by the Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center (GWJJMB202510010098).

AUTHORS’ CONTRIBUTIONS

Wenhui Chang contributed to the conception and design, data analysis, and manuscript writing. Jia Xu and Ying Yu provided research guidance and revised the manuscript. Yayu Zhao participated in data collection and data analysis. Xinru Wei and Xiaoqi Li were involved in data collection. All authors have read and approved the final version of the manuscript.

REFERENCES

1. Li Z, Li Z, Menghua C, Xiaonong C, Lingying G. Expert consensus on the selection of blood purification modalities (2025 edition). Chin J Blood Purif. 2025; 24: 705-725.

2. Tanaka T, Hirano H, Ikebe K, Ueda T, Iwasaki M, Minakuchi S, et al. Consensus statement on “Oral frailty” from the Japan Geriatrics Society, the Japanese Society of Gerodontology, and the Japanese Association on Sarcopenia and Frailty. Geriatr Gerontol Int. 2024; 24: 1111-1119.

3. M NK, K N RS, H M T, Kamath G, D D. Prevalence of xerostomia in patients on haemodialysis: A systematic review and meta-analysis. Gerodontology. 2021; 38: 235-241.

4. Schmalz G, Patschan S, Patschan D, Ziebolz D. Oral health-related quality of life in adult patients with end-stage kidney diseases undergoing renal replacement therapy - a systematic review. BMC Nephrol. 2020; 21: 154.

5. Zhang Q, Zhang Y, Lin L, Meng F, Jia M. Factors affecting the oral health of patients on maintenance hemodialysis and recommendations for standardized nursing care: a multicenter study. Quintessence Int. 2024; 55: 580-588.

6. Miyasato K, Kobayashi Y, Ichijo K, Yamaguchi R, Takashima H, Maruyama T, et al. Oral Frailty as a Risk Factor for Malnutrition and Sarcopenia in Patients on Hemodialysis: A Prospective Cohort Study.Nutrients. 2024; 16: 3467.

7. Guise JM, Chang C, Viswanathan M, Glick S, Treadwell J, Umscheid CA, et al. Agency for Healthcare Research and Quality Evidence-based Practice Center methods for systematically reviewing complex multicomponent health care interventions. J Clin Epidemiol. 2014; 67: 1181-1191.

8. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-605.

9. Iwasaki M, Ohta Y, Furusho N, Kakuta S, Muraoka K, Ansai T, et al. Association between oral frailty and nutritional status among hemodialysis patients aged ≥50 years. Geriatr Gerontol Int. 2024; 24: 891-897.

10. Junkai D, Li L, Yan M, Liang Y, Huan L, Xuezhi S. Current situation and influencing factors of oral frailty in maintenance hemodialysis patients. Chin J Blood Puri. 2024; 23: 86-90.

11. Chen M, He M, Gu Q, Gao X, Lu G. The current status and influencing factors of oral frailty in elderly maintenance hemodialysis patients based on the Andersen Oral Health Outcome Model. BMC Oral Health. 2024; 24: 1085.

12.  Yan M, Annuo L, Junkai D,Liang Y, Xueqing L, YUyu Z. The correlation between oral frailty and sarcopenia in maintenance hemodialysis patients. Chin J Blood Puri. 2025; 24: 255-259.

13. Xinyu W, Xiaoxia C, Li C, Lixiang Y, Xiaoshan W. Study on the correlation between oral frailty and oral dryness in maintenance hemodialysis patients. J Mod Med Health. 2025; 41: 2864-2869.

14. Tianqi L, Xinrong X, Jianping Y. Analysis of current status and influencing factors of oral frailty in elderly maintenance hemodialysis patients. Geriatr Health Care. 2025; 31: 1479-1483.

15. Hu S, Li X. An analysis of influencing factors of oral frailty in the elderly in the community. BMC Oral Health. 2024; 24: 260.

16. Honarmand M, Farhad-Mollashahi L, Nakhaee A, Sargolzaie F. Oral manifestation and salivary changes in renal patients undergoing hemodialysis. J Clin Exp Dent. 2017; 9: e207-e210.

17. Veisa G, Tasmoc A, Nistor I, Segall L, Siriopol D, Solomon SM, et al. The impact of periodontal disease on physical and psychological domains in long-term hemodialysis patients: a cross-sectional study. Int Urol Nephrol. 2017; 49: 1261-1266.

18. Chen Y, Zhang L, Yan W, Liu F. Factors associated with oral frailty in older adults: a systematic review and meta-analysis. Front Public Health. 2025; 13: 1688322.

19. Irie K, Mochida Y, Altanbagana NU, Fuchida S, Yamamoto T: Relationship between risk of oral frailty and awareness of oral frailty among community-dwelling adults: a cross-sectional study. Sci Rep. 2024; 14: 433.

20. Saengtipbovorn S, Taneepanichskul S. Effectiveness of lifestyle change plus dental care (LCDC) program on improving glycemic and periodontal status in the elderly with type 2 diabetes. BMC Oral Health. 2014; 14: 72.

21. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21: 300-307.e2.

22. Tagliafico AS, Bignotti B, Torri L, Rossi F. Sarcopenia: how to measure, when and why. Radiol Med. 2022; 127: 228-237.

23. Kugimiya Y, Iwasaki M, Ohara Y, Motokawa K, Edahiro A, Shirobe M, et al. Association between sarcopenia and oral functions in community-dwelling older adults: A cross-sectional study. J Cachexia Sarcopenia Muscle. 2023; 14: 429-438.

24. Lee SY, Lee HJ, Lim JY. Effects of leucine-rich protein supplements in older adults with sarcopenia: A systematic review and meta-analysis of randomized controlled trials. Arch Gerontol Geriatr. 2022; 102: 104758.

Other Articles

Article Image 1

High-Dose Statin Associated with Rhabdomyolysis, Acute Kidney Injury, Cholestatic Liver Injury, and Thrombocytopenia

Introduction: Statins are the drugs of choice to reduce cholesterol and the incidence of cardiovascular events. Although rare, the side effects of these drugs may be severe (especially when given in the high doses recommended by the cardiologists), including: muscle damage, renal and liver injury and compromised function, and polyneuropathy.

Case Report: We report a case of statin-induced rhabdomyolysis, acute kidney and liver failure and thrombocytopenia that developed in a 76-year-old man, who was referred to our department because of severe generalized myalgia and muscle weakness, extreme fatigue, loss of appetite, dark brown urine. Following an acute myocardial infarction 8 months previously he was put on atorvastatin 80 mg once daily. Laboratory evaluation at presentation revealed much increased levels of muscle enzymes, aminotransferases, total and conjugated bilirubin, and nitrogenous waste products, and low platelets. A diagnosis of acute renal and liver failure secondary to the long-term intensive statin therapy was made. Atorvastatin was discontinued and forced alkaline diuresis was started. After five days of oliguria and slight but persistent increase in creatinine levels dialysis was initiated, but discontinued after 4 sessions, once urine output increased. At discharge the patient’s serum creatine kinase level was in the normal range, creatinine was significantly decreased the thrombocyte count was better, aminotransferase were much lower but not completely normalized, but the bilirubin remained at the same level. The patient was discharged and instructed to avoid any potentially nephrotoxic and hepatotoxic drugs until next outpatient evaluation.

Conclusions: Our case report is meant to raise concerns about prescribing high dose statins. Unfortunately the prescribing cardiologists may be insufficiently aware of the potential for severe adverse effects as these come to the attention of clinicians from different specialities, especially nephrologists.

Dorin Dragos1,2, Diana Pruteanu2 and Rodica Constantin2


Article Image 1

Infections in Pediatric Dialysis Patients in Mubarak Al-Kabeer Hospital, Kuwait: 10 Year

Objective: As the incidence of End Stage Renal Disease (ESRD) worldwide has increased, so has the need for performing Hemodialysis (HD) and Peritoneal Dialysis (PD). We sought to identify risk factors and measure the rate of infections in pediatric patients undergoing dialysis.

Design: A retrospective study

Setting: Single pediatric dialysis center in Kuwait from July 2003-July 2013

Subjects: Pediatric patients undergoing PD or HD

Interventions: Follow up of risk factors and rate of infections incidents

Main outcome measures: Risk factors, incidence rate of infections and microbiological profile of organisms causing dialysis-related infections were determined in HD or PD patients.

Results: A total of 91 patients underwent HD and 63 patients underwent PD. The episodes of infection were documented in 13 patients in each of the two groups. Our rates of infection were found to be one peritonitis episode per 20 patient-months in PD group and 0.41 infection episodes per patient-year in HD group. The commonest organisms isolated in PD-related infections were Pseudomonas aeruginosa and CoagulaseNegative Staphylococci (CNST) whereas in HD-related infections CNST was the leading organism. Among the risk factors in both groups, personal hygiene was the most significant with a P-value of

Conclusion: Our infection rates were consistent with international reports and consistent with others in proving poor personal hygiene as a significant risk factor for infection in patients undergoing renal dialysis.

Wadha Alfouzan¹˒²*, Faisal Alkandari³, Ayman Yosri³, Fawaz Azizieh⁴, Haya Al Tawalah⁵ and Dhar R²


Article Image 1

Evaluating the Kidney Stones; are the Volume and Size Equal in One or Two Dimensions? Accustomed Inaccuracy

Urinary lithiasis is a common disease, prevalence rates vary from 1% to 20%, according to gender, dietary, ethnic, the geographical, and genetic factors.

Musab Ilgi*, Kaya Horasanli and Sinan Levent Kirecci


Article Image 1

Biochemical and Histological Evaluation of Kidney Function in Rats after a Single Administration of Cyclophosphamide and Ifosfamide

Background: Cyclophosphamide (CP) and Ifosfamide (IF) are widely used cytotoxic agents. Both CP and IF exert some characteristic adverse drug reactions including kidney damage taking various clinical forms, depending on the applied dose or administration route. The aim of our study was to estimate kidney function using selected, classical biochemical parameters as well as analyzing the urinary concentration and excretion of a modern “kidney troponin” - neutrophil gelatinase-associated lipocalin-1 (NGAL-1) in rats after administration of a single CP or IF dose.

Methods: 30 rats were divided into three groups (n=10 each; half males and females): group 1 - control (rats receiving i.p. saline solution); groups 2 and 3 – rats intraperitoneally treated with a single CP or IF dose of 150 mg/kg b.w., respectively. Following saline/CP/IF administration, animals were housed in single metabolic cages, to assess 24-hour diuresis and to obtain urinary samples for further laboratory assays. Finally, blood samples were collected and rats were sacrificed to perform autopsy with cystectomy and nephrectomy with subsequent histopathological analysis. Standard parameters of kidney function were assayed either in blood or in urine with an additional assessment of the urine NGAL-1 level.

Results: Single administration of both CP and IF resulted in decreased pH of urine and proteinuria accompanied by an increased 24-hour urinary NGAL-1 excretion. Moreover, CP-treated rats demonstrated polyuria. Concentrations and 24-hour excretion of most classical, low-weight parameters were not different in both CP- and IF-treated rats compared to values observed in control animals.

The histopathological analysis in CP/IF treated animals revealed presence of cystic inflammatory lesions and a normal kidney structure, with the exception of a mild to moderate congestive hyperemia.

Conclusion: A single administration of CP and IF caused a functional kidney tubulopathy in study rats manifested by marked proteinuria with increased 24-hour NGAL-1 urinary excretion.

Łukasz Dobrek*, Agnieszka Baranowska, Beata Skowron and Piotr Thor


Article Image 1

Serum Glycoprotein Chondrex (YKL-40) and High Sensitivity C- Reactive Protein (hscrp) in Type 2 Diabetic Patients in Relation to Cardiovascular Complications

In Type 2 diabetes, C-Reactive Protein (CRP) as an inflammatory marker may be elevated. The glycoprotein Chondrex or YKL-40 is over expressed in many inflammatory conditions. The aim is to study serum hsCRP and YKL-40 in Type 2 diabetic patients in relation to cardiovascular complications.

Methods: Eighty subjects were divided into 3 groups: GROUP 1:16 apparently healthy controls, GROUP 2:16 patients suffering from Type 2 DM without cardiovascular complications and GROUP 3: 48 patients suffering from Type 2 DM with cardiovascular complications. Subjects with acute or chronic inflammation, autoimmune disease or malignancy were excluded. Electrocardiography, Carotid Intima Thikness, Fundus Examination, laboratory investigations: (Complete urine analysis, urinary albumin, Creatinine and calculation of urinary albumin to creatinine ratio, fasting and postprandial glucose, glycated hemoglobin, Creatinine and uric acid, lipid profile, glomerular filtration rate, CRP and YKL-40) were done to all subjects.

Results: High sensitivity CRP levels were significantly elevated in the diabetic group with cardiovascular complications when compared to the diabetic group without cardiovascular complications (p=0.024). YKL-40 was significantly higher in patients with type 2 diabetes mellitus than controls (p=0.017) and cardiovascular complications (p<0.001) contributed to its greater elevation.YKL-40 was positively correlated with triglycerides, systolic and mean blood pressure in the group of diabetic patients without cardiovascular complications and with duration of diabetes and urinary albumin to creatinine ratio in the group with cardiovascular complications. By drawing receiver operating characteristic (ROC) curve between diabetic patients without and with cardiovascular complications the AUC for hsCRP was (0.676, p=0.036) and for YKL-40 was (0.743, p=0.004). By studying the diagnostic performance, YKL-40 had a better specificity and positive predictive value than hsCRP.

Conclusion: YKL-40 has a better specificity and positive predictive value than hsCRP in discriminating between diabetic patients with cardiovascular complications from those without cardiovascular complications.

El-Attar HA¹*, El-Deeb MM¹ and El-Ghlied LA²


Article Image 1

Is There An Association Between Angiotensin II Type 1 Receptor A1166C Gene Polymorphism and Renal Scarring Susceptibility?

Relationship between Angiotensin II Type 1 Receptor (AT1R) A1166C gene polymorphism and renal scarring risk is still controversial. This meta-analysis was performed to evaluate the association of AT1R A1166C gene polymorphism and renal scarring risk susceptibility. A predefined literature search and selection of eligible relevant studies were performed to collect data from electronic databases of PubMed, Embase and Cochrane Library. Three literatures were identified and included for the analysis of the relationship between AT1R A1166C gene polymorphism and renal scarring risk. We found that AT1R A1166C gene polymorphism was not associated with renal scarring susceptibility using the comparison of patients with scarring vs patients without scarring (C: OR=1.33, 95%CI: 0.83-2.13, P=0.23; CC: OR=1.71, 95%CI: 0.22-13.56, P=0.61; AA: OR=0.69, 95%CI: 0.39-1.21, P=0.20). Furthermore, AT1R A1166C gene polymorphism was also not associated with renal scarring risk using the comparison of patients with scarring vs healthy control. In conclusion, AT1R A1166C gene polymorphism was not associated with renal scarring risk susceptibility. However, more studies should be performed in the future.

Tianbiao Zhou*#, Weiji Xie#, Zhijun Lin# and Zhensheng Yang


Article Image 1

Evaluation of Antidiabetic Plants used by Tribes of Telangana State on Diabetic Complications like Neuropathy, Nephropathy and Cardiomyopathy in Rats

Background: India is “diabetes capital of the world”. Diabetes Atlas 2006 published by International Diabetes Federation, India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. Over the past 30 yr, the status of diabetes has changed from being considered as a mild disorder to major causes of morbidity and mortality.

Methods: Rats treated with Alloxan (150 mg/kg) i.p. results diabetic rats given ethanol extract of Senna auriculata leaf, Syzygium cumini (L.) Skeels seeds and Syzygium cumini (L.) Skeels seeds (150 mg/kg) p.o., respectively for 42 days. Biochemical parameters of diabetic neuropathy, nephropathy and cardiomyopathy and histopathology of sciatic nerve, kidney and heart was done at the end of study.

Results: In Diabetic Group found Blood Glucose Level (BGL) (84.42±6.384 to 369.36±7.784mg/dl); Muscle Grip Strength (MGS) (59.32±1.052 to 13.52±0.883seconds); Thermal Pain Response (TPR) (5.55±0.621 to 13.67±1.164seconds). blood protein (7.48±0.051 to 25.18±0.046mg/dl); urine protein (0.692±0.061 to 2.68±0.056mg/dl); blood albumin (1.94±0.043 to 0.248±0.007mg/dl); urine albumin (0.082±0.009 to 2.68±0.056mg/dl); blood myoglobin (0.042±0.00274 to 0.056±0.00207ng/dl); urine myoglobin (0.0048±0.00142 to 0.0098±0.00107mg/dl); Blood Urea Nitrogen (BUN) (23.04±1.093 to 124.81±1.238 mg/dl); Serum Creatinine (84.06±6.723 to 218.56±7.586 (µMol/dl). Etholic extract of Senna auriculata leaf, Phyllanthus emblica.L. fruits and Syzygium cumini (L.) Skeels seeds & combination treated groups found BGL124.42±7.042, 112.07±6.942, 126.25±7.051 & 98.83±6.932mg/dl; MGS 49.06±0.962, 52.05±1.247, 54.06±1.268 & 56.79±1.125 seconds; TPR 6.54±0.841, 7.38±0.802, 6.45±1.062 & 6.14±0.837 seconds; blood protein 7.98±0.039, 8.02±0.053, 8.06±0.039 & 7.48±0.045mg/dl; urine protein 1.22±0.058, 0.94±0.049, 0.96±0.056 & 0.82±0.062mg/dl; blood albumin 1.64±0.033, 1.82±0.036, 1.87±0.044 & 1.96±0.039mg/dl; urine albumin 0.122±0.008, 0.098±0.007, 0.132±0.009 & 0.108±0.011mg/dl; blood myoglobin 0.045±0.00189, 0.036±0.00177, 0.041±0.00223 & 0.043±0.00175ng/dl; urine myoglobin 0.0042±0.00129, 0.0052±0.00119, 0.0064±0.00126 & 0.0036±0.00125mg/dl; BUN 35.81±1.186, 36.06±1.123, 34.53±1.177 & 29.03±1.229mg/dl; Serum Creatinine 98.42±5.526, 99.73±6.064, 101.97±6.052 & 94.83±6.678µMol/dl.

Conclusion: Ethanol extract of Senna auriculata leaf, Phyllanthus emblica L. fruit and Syzygium cumini (L.) Skeels seeds (150mg/kg) and its combination normalizes biochemical parameters & Morphological changes in sciatic nerve, myocardium & kidney and improvement of the general behavioral parameters. Combination was found to be more effective in these diabetic complications.

Syed Ahmed Hussain and Ashish Kumar Sharma*


Article Image 1

Uric Acid, Metabolic Risk Factors, and Chronic Kidney Disease: Clinical Investigation in a Female Elderly Occupational Population in Taipei, Taiwan

Purpose: To explore the prevalence and associated factors for Chronic Kidney Disease (CKD) among female elderly fishing and agricultural population in Taipei, Taiwan.

Methods: Females (n=1,606) aged 65 years and over voluntarily admitted to a teaching hospital for a physical check-up were collected in 2010.

Results: The prevalence of CKD was 8.2%. Age, hyperuricemia, and hyperglycemia were statistical significantly related to CKD. The sensitivity and specificity of serum uric acid and fasting blood glucose concentration as a marker of CKD were estimated 76.5%, 70.9% and 51.5%, 53.5%, respectively.

Conclusion: Hyperuricemia and hyperglycemia independently affect the prevalent CKD in this sub-population.

Ya-Ting Liang¹, Hsi-Che Shen²˒³˒⁴, Yi-Chun Hu²˒³˒⁵, Yu-Fen Chen⁶˒⁷˒⁸ and Tao-Hsin Tung⁹˒¹⁰˒¹¹*


Article Image 1

Pseudohypercreatininemia after Sustanon Injection

The drugs used in the treatment of certain diseases may give impression of impaired renal function. These drugs cause a false high serum creatinine level. Laboratory findings other than serum creatinine and hypertriglyceridemia were normal. We presented a 28-year-old male with a high serum creatinine level, who was referred for consideration of urgent renal replacement therapy. The results of the investigations revealed that the result was the falsely-elevated serum creatinine due to the sustenance injection.

Can Hüzmeli¹, Mustafa Sağlam¹, Bariş Döner¹, Serkan Çağlar² and Özkan Güngör³


Article Image 1

Peripheral Arterial Disease Holding Central Stage in Chronic Kidney Disease (Kdoqi Stage 3-5): Prevalence and Related Risk Factors - Experience from Kashmir Valley Tertiary Care Centre

Patients with CKD are highly predisposed for developing accelerated atherosclerosis. These patients have non-traditional risk factors such inflammation, malnutrition and increased oxidative stress that enhance and accelerate atherosclerosis in addition to traditional risk factors. Although relation between cardiovascular and cerebrovascular diseases with CKD is well established, studies are suggesting about association of Peripheral Arterial Disease (PAD) with CKD. PAD is associated with increased morbidity and mortality in patients of CKD.

This study is rendezvous to look for PAD and related risk factors in patients of CKD having eGFR less than 60 ml/ min/ 1.73 m2 (MDRDS) and not on RRT.

Two hundred ten subjects with CKD attending department of nephrology at tertiary care institute in valley were included in study. Out of 210 subjects selected, 30 were having PAD that constituted 14% of study population. IC was seen in 25 (11.9%) of 210 subjects. Out of PAD patients 16 (53.3%) were having history of IC and 14 (46.7%) were asymptomatic. As reported in literature, prevalence of peripheral arterial disease in CKD patients not on dialysis ranged from 7% to 32% in previous cases. This study will sensitize us to plan more effective screening, preventive and management strategies. This will go long way to decrease morbidity and mortality in patients.

Mohamad Muzzafer Mir*, Mohamad Saleem Najar, Bipin Kumar Sharma, Mangit Singh, Ursilla Taranum Mir and Majid Khalil Rather